Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory study on cultured human cells
PubMed 18221377 · doi:10.1111/j.1471-4159.2008.05241.x
What was done
Investigators evaluated the expression and activity of the l-tryptophan catabolic kynurenine pathway in cultured human blood-brain barrier endothelial cells and pericytes under baseline and immune-activated conditions using RT-PCR and HPLC/GC-MS.
What was found
The abstract reports no numerical values, concentrations, or effect sizes. Qualitatively, human blood-brain barrier endothelial cells and pericytes constitutively expressed kynurenine pathway components. Endothelial cells constitutively produced kynurenic acid and secreted kynurenine basolaterally after immune activation; pericytes produced baseline picolinic acid and produced kynurenine following immune activation.
Why it matters
The study identifies a potential cellular mechanism by which systemic inflammatory signals could be transmitted across an intact blood-brain barrier through basolateral kynurenine secretion, serving as a substrate for downstream neurotoxic quinolinic acid production.
Limits
The abstract provides no quantitative data, sample sizes, or replication counts. Findings are derived entirely from in vitro cell models, lacking in vivo confirmation or clinical evaluation in human patients.
Cited by
- context Quinolinic acid in systemic circulation causes the activation of macrophages and activation of microglia in the brain.